Apeiron Investment Group Ltd. insider trades
Apeiron Investment Group Ltd. has filed 19 Form 4s with the SEC that we hold, for ATAI (Director, 10% owner), Enhanced Group Inc. (ENHA) (Director, 10% owner), Alto Neuroscience, Inc. (ANRO) (Reporting owner) and AtaiBeckley Inc. (ATAI) (Director, 10% owner), among 6 companies in all. Across all of them we count 23 purchases worth $57.2M and 3 sales worth $82.5K reported on Form 4. In the last 12 months: 11 purchases ($11.1M) and 0 sales ($0). The largest single trade was a purchase of 10,835,718 shares of ATAI worth $22.8M, dated 2025-02-14. The first filing on our record is dated 2022-04-12 and the latest 2026-09-21.
ATAI (ATAI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-08 | P, purchase reported on Form 4 | 57,689 | $277.5K | 2022-04-12 |
| 2022-04-11 | P, purchase reported on Form 4 | 53,926 | $260.5K | 2022-04-12 |
| 2022-04-14 | P, purchase reported on Form 4 | 4,967 | $25.8K | 2022-04-18 |
| 2022-04-18 | P, purchase reported on Form 4 | 54,322 | $277.6K | 2022-04-20 |
| 2022-04-19 | P, purchase reported on Form 4 | 65,315 | $335.1K | 2022-04-20 |
| 2022-04-20 | P, purchase reported on Form 4 | 67,703 | $344.6K | 2022-05-03 |
| 2022-04-21 | P, purchase reported on Form 4 | 68,688 | $340.0K | 2022-05-03 |
| 2025-02-14 | P, purchase reported on Form 4 | 10,835,718 | $22.8M | 2025-02-19 |
| 2025-03-24 | P, purchase reported on Form 4 | 1,800,000 | $2.5M | 2025-03-24 |
| 2025-08-14 | P, purchase reported on Form 4 | 8,675,799 | $19.0M | 2025-08-18 |
Enhanced Group Inc. (ENHA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-14 | P, purchase reported on Form 4 | 150,000 | $295.6K | 2026-08-17 |
| 2026-08-17 | P, purchase reported on Form 4 | 200,000 | $330.4K | 2026-08-18 |
| 2026-08-18 | P, purchase reported on Form 4 | 93,000 | $158.2K | 2026-08-20 |
| 2026-08-19 | P, purchase reported on Form 4 | 1,619,316 | $2.7M | 2026-08-20 |
| 2026-08-19 | P, purchase reported on Form 4 | 55,000 | $90.4K | 2026-08-20 |
| 2026-09-02 | P, purchase reported on Form 4 | 107,693 | $169.6K | 2026-09-04 |
| 2026-09-03 | P, purchase reported on Form 4 | 25,414 | $40.2K | 2026-09-04 |
| 2026-09-04 | P, purchase reported on Form 4 | 21,034 | $33.9K | 2026-09-09 |
| 2026-09-08 | P, purchase reported on Form 4 | 59,337 | $93.1K | 2026-09-09 |
| 2026-09-09 | P, purchase reported on Form 4 | 99,342 | $159.4K | 2026-09-09 |
| 2026-09-17 | P, purchase reported on Form 4 | 6,080,047 | $7.0M | 2026-09-21 |
Alto Neuroscience, Inc. (ANRO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
AtaiBeckley Inc. (ATAI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
BNOX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-10-02 | S, sale reported on Form 4 | 90,806 | $30.0K | 2024-10-07 |
| 2024-10-03 | S, sale reported on Form 4 | 180,707 | $52.4K | 2024-10-07 |
| 2024-10-04 | S, sale reported on Form 4 | 557 | $156 | 2024-10-07 |
Faeth Therapeutics, Inc. (SNSE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-02-23 | P, purchase reported on Form 4 | 1,100 | $1.8K | 2023-02-27 |
| 2023-02-23 | P, purchase reported on Form 4 | 1,100 | $1.8K | 2023-02-27 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1845711) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms